SCHEMBL4946111

SCHEMBL4946111

C#CCNC1(OC(=O)N(C)CC)CCc2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ACHE P22303 13/20 0.41
MAOA P21397 4/20 0.41
MAOB P27338 4/20 0.41
BCHE P06276 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16192661 0.81 HDAC9 (0.35) MAOAMAOB
SCHEMBL2028968 0.78 SIGMAR1 (0.38)
SCHEMBL6472053 0.76 ACHE (0.38) ACHE
Hydrochloric Acid SCHEMBL333583 0.75 ACHE (0.39) ACHE
SCHEMBL1051970 0.74 MAOB (0.39) ACHEMAOAMAOBBCHE
SCHEMBL4348712 0.69 MAOB (0.38) ACHEMAOAMAOBBCHE
SCHEMBL7947368 0.66 MAOB (0.41) ACHEMAOAMAOBBCHE
SCHEMBL5807645 0.66 KDM1A (0.40) ACHEMAOAMAOBBCHE
SCHEMBL7341859 0.66 MAOB (0.38) ACHEMAOAMAOBBCHE
SCHEMBL3421261 0.65 HDAC9 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1956904-A2 USE OF LOW-DOSE LADOSTIGIL FOR NEUROPROTECTION Yissum Research Development Company, of The Hebrew University of Jerusalem (IL) 2008-08-20 EP claimed
WO-2007070425-A2 USE OF LOW-DOSE LADOSTIGIL FOR NEUROPROTECTION YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2007-06-21 WO claimed